🟧 Definium Therapeutics at Jefferies Global Healthcare Conference in New York June 2026 🟧
Rob, Dan, and Brandi from Definium Therapeutics answer questions about their flagship drug DT120 and upcoming Phase 3 readouts at the Jefferies Global Healthcare Conference in New York June 2026. Audio has been enhanced for clarity.
▶︎
The Business of Recovery: Jeremy Hollembeak on Asset Tracing, Insolvency, and Litigation Strategy
▶︎
Forget Zepbound: 15 New Obesity Drugs Are Coming
▶︎
Conan O’Brien Mocks Trump At Harvard Commencement | Crowd Erupts During Viral Speech
▶︎
Super-KI? Die große Lüge der Tech-Konzerne
▶︎
Dr David Sinclair: Can Aging Be Reversed? After 8 Weeks, Cells Appeared 75% Younger In Tests!
▶︎
Leading in the Age of AI: A Conversation with NVIDIA CEO Jensen Huang | Global Conference 2026
▶︎
10-Minute Match: Brazil vs Germany | 2014 FIFA World Cup Semi-Final
▶︎
S13 E16: Iran Peace Deal & Feral Hogs: 6/21/26: Last Week Tonight with John Oliver
▶︎
Putin will lose Crimea: Ukraine is crippling Russia’s supply lines | Lt Gen Ben Hodges
▶︎
Golden Retriever Meets Completely Broken Rescue for the First Time
▶︎
Scientists Discovered a Supplement That Lowers Cholesterol AND Excretes Toxins
▶︎
Sponsor Perspective: Definium Therapeutics | Rethinking Psychedelic Treatment for Mental Health
▶︎
Peptide Expert: What Do Peptides Actually Do? (EXPLAINED) - Dr Alex Tatem
▶︎
Health and Life Sciences: research integrity under the microscope
▶︎
Retatrutide Dosing Explained (Doctor Breaks Down the Data)
▶︎
Healthy Aging through Post-Traumatic Growth - Jewish Federations' Showcase 2026
▶︎
💊 The Psychedelic Countdown: From Clinical Trials to Clinical Practice 💊
▶︎
AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎
The New Peptide Craze: Is Any of This Safe?
▶︎